Documenta Ophthalmologica

, 118:63 | Cite as

The role of the ERG in the diagnosis and treatment of Age-Related Macular Degeneration

  • Christina Gerth


Age-related macular degeneration (AMD) is affecting an increasing number of people, with 2.95 million people estimated to be affected in the USA by 2020. Possible preventive agents, such as vitamins and supplements have been studied and new treatment options for AMD have been developed in recent years. What role does electrophysiology play as a sensitive outcome measure? The most commonly used tests are the full-field electroretinogram (ffERG) and the multifocal ERG (mfERG). Test results from patients with AMD and reduced central vision need special attention in respect to fixation pattern, age-matched control data, and retinal luminance. Advantages, disadvantages and limitations of techniques will be considered, together with a review of published studies.


ERG mfERG AMD Outcome measure 



I thank Carole Panton for editorial comments.


  1. 1.
    Klein R, Klein BE, Linton KL (1992) Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 99:933–943PubMedGoogle Scholar
  2. 2.
    Brown GC, Brown MM, Campanella J, Beauchamp GR (2005) The cost-utility of photodynamic therapy in eyes with neovascular macular degeneration – a value-based reappraisal with 5-year data. Am J Ophthalmol 140:679–687PubMedGoogle Scholar
  3. 3.
    Coleman AL, Yu F (2008) Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999. Ophthalmology 115:18–25CrossRefPubMedGoogle Scholar
  4. 4.
    Klein R, Klein BE, Jensen SC, Meuer SM (1997) The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 104:7–21PubMedGoogle Scholar
  5. 5.
    Bressler NM, Munoz B, Maguire MG et al (1995) Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study. Arch Ophthalmol 113:301–308PubMedGoogle Scholar
  6. 6.
    Bressler NM, Bressler SB, Fine SL (1988) Age-related macular degeneration. Surv Ophthalmol 32:375–413CrossRefPubMedGoogle Scholar
  7. 7.
    Wong T, Chakravarthy U, Klein R et al (2008) The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology 115:116–126CrossRefPubMedGoogle Scholar
  8. 8.
    Schmidt-Erfurth UM, Pruente C (2007) Management of neovascular age-related macular degeneration. Prog Retin Eye Res 26:437–451CrossRefPubMedGoogle Scholar
  9. 9.
    Andreoli CM, Miller JW (2007) Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol 18:502–508CrossRefPubMedGoogle Scholar
  10. 10.
    Ferris FL 3rd, Kassoff A, Bresnick GH, Bailey I (1982) New visual acuity charts for clinical research. Am J Ophthalmol 94:91–96PubMedGoogle Scholar
  11. 11.
    Birch DG, Anderson JL (1992) Standardized full-field electroretinography. Normal values and their variation with age. Arch Ophthalmol 110:1571–1576PubMedGoogle Scholar
  12. 12.
    Weleber RG (1981) The effect of age on human cone and rod Ganzfeld electroretinograms. Invest Ophthalmol Vis Sci 20:392–399PubMedGoogle Scholar
  13. 13.
    Wright CE, Williams DE, Drasdo N, Harding GFA (1985) The influence of age on the electroretinogram and visual evoked potential. Doc Ophthalmol 59:365–384CrossRefPubMedGoogle Scholar
  14. 14.
    Seeliger MW, Kretschmann UH, Apfelstaedt-Sylla E, Zrenner E (1998) Implicit time topography of multifocal electroretinograms. Invest Ophthalmol Vis Sci 39:718–723PubMedGoogle Scholar
  15. 15.
    Fortune B, Johnson CA (2002) The decline of photopic multifocal electroretinogram responses with age is primarily due to pre-retinal optical factors. J Opt Soc Am A 19:173–184CrossRefGoogle Scholar
  16. 16.
    Gerth C, Garcia SM, Ma L et al (2002) Multifocal electroretinogram: age-related changes for different luminance levels. Graefes Arch Clin Exp Ophthalmol 240:202–208CrossRefPubMedGoogle Scholar
  17. 17.
    Tzekov RT, Gerth C, Werner JS (2004) Senescence of human multifocal electroretinogram components: a localized approach. Graefes Arch Clin Exp Ophthalmol 242:549–560CrossRefPubMedGoogle Scholar
  18. 18.
    Jackson GR, McGwin G Jr, Phillips JM et al (2004) Impact of aging and age-related maculopathy on activation of the a-wave of the rod-mediated electroretinogram. Invest Ophthalmol Vis Sci 45:3271–3278CrossRefPubMedGoogle Scholar
  19. 19.
    Hogg RE, Chakravarthy U (2006) Visual function and dysfunction in early and late age-related maculopathy. Prog Retin Eye Res 25:249–276CrossRefPubMedGoogle Scholar
  20. 20.
    Medeiros NE, Curcio CA (2001) Preservation of ganglion cell layer neurons in age-related macular degeneration. Invest Ophthalmol Vis Sci 42:795–803PubMedGoogle Scholar
  21. 21.
    Curcio CA, Medeiros NE, Millican CL (1996) Photoreceptor loss in age-related macular degeneration. Invest Ophthalmol Vis Sci 37:1236–1249PubMedGoogle Scholar
  22. 22.
    Jackson GR, McGwin G Jr, Phillips JM et al (2006) Impact of aging and age-related maculopathy on inactivation of the a-wave of the rod-mediated electroretinogram. Vision Res 46:1422–1431CrossRefPubMedGoogle Scholar
  23. 23.
    Feigl B, Brown B, Lovie-Kitchin J, Swann P (2005) Cone- and rod-mediated multifocal electroretinogram in early age-related maculopathy. Eye 19:431–441CrossRefPubMedGoogle Scholar
  24. 24.
    Chen C, Wu L, Wu D et al (2004) The local cone and rod system function in early age-related macular degeneration. Doc Ophthalmol 109:1–8PubMedGoogle Scholar
  25. 25.
    Ronan S, Nusinowitz S, Swaroop A, Heckenlively JR (2006) Senile panretinal cone dysfunction in age-related macular degeneration (AMD): a report of 52 AMD patients compared to age-matched controls. Trans Am Ophthalmol Soc 104:232–240PubMedGoogle Scholar
  26. 26.
    Walter P, Widder RA, Luke C et al (1999) Electrophysiological abnormalities in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 237:962–968CrossRefPubMedGoogle Scholar
  27. 27.
    Sandberg MA, Miller S, Gaudio AR (1993) Foveal cone ERGs in fellow eyes of patients with unilateral neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 34:3477–3480PubMedGoogle Scholar
  28. 28.
    Falsini B, Serrao S, Fadda A et al (1999) Focal electroretinograms and fundus appearance in nonexudative age-related macular degeneration. Quantitative relationship between retinal morphology and function. Graefes Arch Clin Exp Ophthalmol 237:193–200CrossRefPubMedGoogle Scholar
  29. 29.
    Gerth C, Hauser D, Delahunt PB et al (2003) Assessment of multifocal electroretinogram abnormalities and their relation to morphologic characteristics in patients with large drusen. Arch Ophthalmol 121:1404–1414CrossRefPubMedGoogle Scholar
  30. 30.
    Takiura K, Yuzawa M, Miyasaka S (2001) Multifocal electroretinogram in patients with soft drusen in the macula. Invest Ophthalmol Vis Sci 42:S73Google Scholar
  31. 31.
    Gerth C, Delahunt PB, Alam S et al (2006) Cone-mediated multifocal electroretinogram in age-related macular degeneration: progression over a long-term follow-up. Arch Ophthalmol 124:345–352CrossRefPubMedGoogle Scholar
  32. 32.
    Jurklies B, Weismann M, Husing J et al (2002) Monitoring retinal function in neovascular maculopathy using multifocal electroretinography—early and long-term correlation with clinical findings. Graefes Arch Clin Exp Ophthalmol 240:244–264CrossRefPubMedGoogle Scholar
  33. 33.
    Neveu MM, Tufail A, Dowler JG, Holder GE (2006) A comparison of pattern and multifocal electroretinography in the evaluation of age-related macular degeneration and its treatment with photodynamic therapy. Doc Ophthalmol 113:71–81CrossRefPubMedGoogle Scholar
  34. 34.
    Bressler NM, Bressler SB, Haynes LA et al (2005) Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7. Arch Ophthalmol 123:1283–1285Google Scholar
  35. 35.
    Tzekov R, Lin T, Zhang KM et al (2006) Ocular changes after photodynamic therapy. Invest Ophthalmol Vis Sci 47:377–385CrossRefPubMedGoogle Scholar
  36. 36.
    Palmowski AM, Allgayer R, Heinemann-Vernaleken B, Ruprecht KW (2002) Influence of photodynamic therapy in choroidal neovascularization on focal retinal function assessed with the multifocal electroretinogram and perimetry. Ophthalmology 109:1788–1792CrossRefPubMedGoogle Scholar
  37. 37.
    Moschos MM, Panayotidis D, Theodossiadis G, Moschos M (2004) Assessment of macular function by multifocal electroretinogram in age-related macular degeneration before and after photodynamic therapy. J Fr Ophtalmol 27:1001–1006CrossRefPubMedGoogle Scholar
  38. 38.
    Ruther K, Breidenbach K, Schwartz R et al (2003) [Testing central retinal function with multifocal electroretinography before and after photodynamic therapy]. Ophthalmologe 100:459–464PubMedGoogle Scholar
  39. 39.
    Mackay AM, Brown MC, Grierson I, Harding SP (2008) Multifocal electroretinography as a predictor of maintenance of vision after photodynamic therapy for neovascular age-related macular degeneration. Doc Ophthalmol 116:13–18CrossRefPubMedGoogle Scholar
  40. 40.
    Oner A, Karakucuk S, Mirza E, Erkilic K (2005) The changes of pattern electroretinography at the early stage of photodynamic therapy. Doc Ophthalmol 111:107–112CrossRefPubMedGoogle Scholar
  41. 41.
    Shahar J, Avery RL, Heilweil G et al (2006) Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin). Retina 26:262–269CrossRefPubMedGoogle Scholar
  42. 42.
    Manzano RP, Peyman GA, Khan P, Kivilcim M (2006) Testing intravitreal toxicity of bevacizumab (Avastin). Retina 26:257–261CrossRefPubMedGoogle Scholar
  43. 43.
    Heiduschka P, Julien S, Hofmeister S et al (2008) Bevacizumab (Avastin) does not harm retinal function after intravitreal injection as shown by electroretinography in adult mice. Retina 28:46–55PubMedCrossRefGoogle Scholar
  44. 44.
    Maturi RK, Bleau LA, Wilson DL (2006) Electrophysiologic findings after intravitreal bevacizumab (Avastin) treatment. Retina 26:270–274CrossRefPubMedGoogle Scholar
  45. 45.
    Moschos MM, Brouzas D, Apostolopoulos M et al (2007) Intravitreal use of bevacizumab (Avastin) for choroidal neovascularization due to ARMD: a preliminary multifocal-ERG and OCT study. Multifocal-ERG after use of bevacizumab in ARMD. Doc Ophthalmol 114:37–44CrossRefPubMedGoogle Scholar
  46. 46.
    Luke C, Aisenbrey S, Luke M et al (2001) Electrophysiological changes after 360 degrees retinotomy and macular translocation for subfoveal choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol 85:928–932CrossRefPubMedGoogle Scholar
  47. 47.
    Terasaki H, Miyake Y, Suzuki T et al (2002) Change in full-field ERGs after macular translocation surgery with 360 degrees retinotomy. Invest Ophthalmol Vis Sci 43:452–457PubMedGoogle Scholar
  48. 48.
    Terasaki H, Ishikawa K, Niwa Y et al (2004) Changes in focal macular ERGs after macular translocation surgery with 360 degrees retinotomy. Invest Ophthalmol Vis Sci 45:567–573CrossRefPubMedGoogle Scholar
  49. 49.
    Owsley C, Jackson GR, Cideciyan AV et al (2000) Psychophysical evidence for rod vulnerability in age-related macular degeneration. Invest Ophthalmol Vis Sci 41:267–273PubMedGoogle Scholar
  50. 50.
    Feigl B, Brown B, Lovie-Kitchin J, Swann P (2006) The rod-mediated multifocal electroretinogram in aging and in early age-related maculopathy. Curr Eye Res 31:635–644CrossRefPubMedGoogle Scholar
  51. 51.
    Sutter EE, Tran D (1992) The field topography of ERG components in man–I. The photopic luminance response. Vision Res 32:433–446CrossRefPubMedGoogle Scholar
  52. 52.
    Sutter EE (1991) The fast m-transform: a fast computation of cross-correlations with binary m-sequences. Soc Indust Appl Math 20:686–694Google Scholar
  53. 53.
    Hood DC, Li J (1997) A technique for measuring individual multifocal ERG records. Opt Soc Am Trends Opt Photonics 11:33–41Google Scholar
  54. 54.
    Hood DC, Bach M, Brigell M et al (2008) ISCEV guidelines for clinical multifocal electroretinography (2007 edition). Doc Ophthalmol 116:1–11CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  1. 1.Department of OphthalmologyUniversity of RostockRostockGermany

Personalised recommendations